Warren Bobrow
Willem Nissink
Matthias Wittwer
Simon Bailey
As Head of Drug Discovery at Plexium, Simon oversees the company’s efforts to identify novel protein degrader drugs that address significant unmet medical needs. Simon joined Plexium in 2019 bringing more than 25 years’ experience of medicinal chemistry and small molecule drug discovery leadership experience. From 1995-2015, Simon held positions of increasing responsibility at Pfizer including leading the Diabetes and Oncology Medicinal Chemistry Departments.
Andy Pike
Zhengnian Li
Gopal Sapkota
Frank Mercurio
Michael Dabrowski
Michael Dabrowski, PhD, co-founder and CEO of Pelago Bioscience. Michael began his Drug Discovery career as an industrial Masters- and PhD-student at Novo Nordisk and worked as a postdoc on Type 2 diabetes. He then developed a long career at AstraZeneca: from senior scientist and technology expert, to project and scientific leader and manager. Through his diverse career, Michael has built a vast industry network and accumulated experience in Drug Discovery, from active laboratory activity, assay and test development, personnel manager, project management and overall portfolio responsibilities. Michael’s key strengths and experience are in establishing cross functional collaborations and Business Development.